What made Moderna stock pop 10% on Tuesday?

Moderna Inc (NASDAQ: MRNA) popped as much as 10% on Tuesday after a Jefferies analyst made upbeat remarks on new data for its experimental vaccine for head and neck cancer. MRNA-4157 has potential beyond melanoma The biotech giant reported positive early-stage results for its MRNA-4157 in combination with Keytruda (Merck) as a treatment of head […]